Strattera 18mg (Atomoxetine): A Non-Stimulant ADHD Treatment

Strattera 18 mg is a medicine that helps to treat the symptoms of Attention Deficit Hyperactivity Disorder (ADHD). It is a branded drug that contains Atmoxetine as an active ingredient. This medicine helps in improving attention and control hyperactivity and impulsivity in individuals.

What is Generic Strattera and Its Medical Purpose?

Generic Strattera contains the active ingredient Atomoxetine, a selective norepinephrine reuptake inhibitor (SNRI). It is a non-stimulant medication specifically approved for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children, adolescents, and adults. The wide range of available dosages from 10mg to 100mg allows for highly personalized treatment. Lower doses (10mg, 18mg, 25mg) are used to initiate therapy, minimizing initial side effects. Higher doses (40mg, 60mg, 80mg, 100mg) are achieved through gradual titration and are used for maintenance treatment, with the final dose tailored to the individual’s response and weight. This makes it a vital option for those who cannot tolerate or have concerns about stimulant medications.

How Does Atomoxetine Work?

Unlike stimulant medications, Atomoxetine does not act on the dopamine system in the same way. Instead, it works by selectively increasing the levels of norepinephrine in the prefrontal cortex of the brain. Norepinephrine is a key neurotransmitter for regulating attention, impulse control, and executive function. By enhancing norepinephrine signaling, Strattera helps improve focus, reduce distractibility, and control hyperactivity and impulsivity. A key benefit is that it is not a controlled substance because it has no potential for abuse or dependence. It also provides 24-hour symptom control from a single daily dose, offering consistent coverage without the “peak and trough” effects of some short-acting stimulants.

Important Safety Information and Potential Side Effects

While Strattera is non-addictive, it is a powerful medication that requires careful monitoring, especially during dose adjustments. Common side effects can include upset stomach, decreased appetite, nausea, vomiting, dizziness, fatigue, and mood swings. These often subside after the first few weeks of treatment. Two important, though less common, risks require attention:

• Suicidal Ideation: In children and adolescents, Strattera may increase the risk of suicidal thoughts, especially early in treatment. Patients and their families should be vigilant for any sudden changes in mood, behavior, or emergence of suicidal thoughts and report them to a doctor immediately.

• Liver Injury: In rare cases, Strattera can cause severe liver damage. Patients should be aware of warning signs like itching, dark urine, jaundice (yellowing of the skin or eyes), and right upper abdominal pain, and seek immediate medical attention if they occur.

• Cardiovascular Effects: It can increase heart rate and blood pressure, which should be monitored regularly.

Responsible Use and Access Through a Licensed Pharmacy

Strattera is a prescription-only medication. A proper diagnosis of ADHD from a healthcare professional is essential. Because it is not a stimulant, it does not work immediately; it may take 2 to 4 weeks to begin seeing improvements and several more weeks to experience the full benefit at a stable dose. A doctor will start with a low dose and gradually increase it over time to find the most effective and tolerable dose for the individual. For patients in the EU with a valid prescription, generic Strattera is available through licensed pharmacies. Following a verified online medical consultation, it can be dispensed through our EU-based online pharmacy at tapentadolonlinestore.de, where we ensure all prescriptions are validated to support safe and effective long-term management of ADHD symptoms.